You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Patent: 9,873,739

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,873,739
Title:Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4)
Abstract: The disclosure relates to compositions and methods of mitigating tissue damage and fibrosis in a patient by modulating latent transforming growth factor beta binding protein (LTBP4)-induced proteolysis of a Transforming Growth Factor-beta (TGF.beta.) superfamily protein.
Inventor(s): McNally; Elizabeth (Oak Park, IL), Heydemann; Ahlke (Oak Park, IL), Ceco; Ermelinda (Chicago, IL)
Assignee: Ikaika Therapeutics, LLC (Oak Park, IL)
Application Number:13/957,100
Patent Claims:see list of patent claims

Details for Patent 9,873,739

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Ikaika Therapeutics, LLC (Oak Park, IL) 2032-08-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.